Mitotic catastrophe and cancer drug resistance: A link that must to be broken
Abstract
An increased tendency of genomic alterations during the life cycle of cells leads to genomic instability, which is a major driving force for tumorigenesis. A considerable fraction of tumor cells are tetraploid or aneuploid, which renders them intrinsically susceptible to mitotic aberrations, and hence, are particularly sensitive to the induction of mitotic catastrophe. Resistance to cell death is also closely linked to genomic instability, as it enables malignant cells to expand even in a stressful environment. Currently it is known that cells can die via multiple mechanisms. Mitotic catastrophe represents a step preceding apoptosis or necrosis, depending on the expression and/or proper function of several proteins. Mitotic catastrophe was proposed to be an onco-suppressive mechanism and the evasion of mitotic catastrophe constitutes one of the gateways to cancer development. Thus, stimulation of mitotic catastrophe appears to be a promising strategy in cancer treatment. Indeed, several chemotherapeutic drugs are currently used at concentrations that induce apoptosis irrespective of the cell cycle phase, yet are very efficient at triggering mitotic catastrophe at lower doses, significantly limiting side effects. In the present review we summarize current data concerning the role of mitotic catastrophe in cancer drug resistance and discuss novel strategies to break this link.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In absence of p53, mitotic defects can drive a necrotic variant of RCD independent of CASP2 signaling in some settings.
“In the absence of p53, however, mitotic defects appear to drive a necrotic variant of RCD independent of CASP2 signaling (at least in some settings) [990–992].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [991]
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092 · see citing works
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681 · see citing works
Live or let die: the cell's response to p53
Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,177 · see citing works
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,275 · see citing works
The spindle-assembly checkpoint in space and time
Musacchio, A., & Salmon, E. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2163 · Cited by 2,227 · see citing works
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009 · see citing works
Pan-cancer patterns of somatic copy number alteration
Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., Lawrence, M. S., Zhang, C., Wala, J. A., Mermel, C. H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2760 · Cited by 1,843 · see citing works
The DNA damage response and cancer therapy
Lord, C. J., & Ashworth, A. (2012) · Nature · doi:10.1038/nature10760 · Cited by 1,843 · see citing works
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798 · see citing works
The DNA Damage Response: Ten Years After
Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705 · see citing works
Bonnet, S., Archer, S. L., Allalunis‐Turner, J., Haromy, A., Beaulieu, C., Thompson, R. B., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S. B., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530 · see citing works
DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis
Crighton, D., Wilkinson, S., O'Prey, J., Syed, N., Smith, P., Harrison, P. R., Gasco, M., Garrone, O., Crook, T., & Ryan, K. M. (2006) · Cell · doi:10.1016/j.cell.2006.05.034 · Cited by 1,380 · see citing works
The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer
Smith, J., Tho, L. M., Xu, N., & Gillespie, D. A. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380888-2.00003-0 · Cited by 1,279 · see citing works
On the road to cancer: aneuploidy and the mitotic checkpoint
Kops, G. J. P. L., Weaver, B. A. A., & Cleveland, D. W. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1714 · Cited by 1,188 · see citing works
Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
Polo, S. E., & Jackson, S. P. (2011) · Genes & Development · doi:10.1101/gad.2021311 · Cited by 1,092 · see citing works
ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks
Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G. C. M., Lukas, J., & Jackson, S. P. (2006) · Nature Cell Biology · doi:10.1038/ncb1337 · Cited by 1,064 · see citing works
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.
Gartel, A. L., & Tyner, A. L. (2002) · PubMed · Cited by 924 · see citing works
Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis
Holland, A. J., & Cleveland, D. W. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2718 · Cited by 859 · see citing works
Mitotic catastrophe: a mechanism for avoiding genomic instability
Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3115 · Cited by 834 · see citing works
Causes and consequences of aneuploidy in cancer
Gordon, D. J., Resio, B. J., & Pellman, D. S. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3123 · Cited by 818 · see citing works
From polyploidy to aneuploidy, genome instability and cancer
Štorchová, Z., & Pellman, D. S. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1276 · Cited by 810 · see citing works
Centrosome aberrations: cause or consequence of cancer progression?
Nigg, E. A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc924 · Cited by 733 · see citing works
Rajagopalan, H., & Christoph Lengauer, C. (2004) · Nature · doi:10.1038/nature03099 · Cited by 730 · see citing works
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 720 · see citing works
Histone H2AX phosphorylation: a marker for DNA damage.
Sharma, A., Singh, K., & Almasan, A. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-998-3_40 · Cited by 679 · see citing works
Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomesPreprint
Kwon, M., Godinho, S. A., Chandhok, N. S., Ganem, N. J., Azioune, A., Théry, M., & Pellman, D. S. (2008) · Genes & Development · doi:10.1101/gad.1700908 · Cited by 654 · see citing works
Shared and separate functions of polo-like kinases and aurora kinases in cancer
Lens, S. M. A., Voest, E. E., & Medema, R. H. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2964 · Cited by 597 · see citing works
Boveri, T. (2007) · Journal of Cell Science · doi:10.1242/jcs.025742 · Cited by 575 · see citing works
Centrosome Amplification Can Initiate Tumorigenesis in Flies
Basto, R., Brunk, K., Vinadogrova, T., Peel, N., Franz, A., Khodjakov, A. L., & Raff, J. W. (2008) · Cell · doi:10.1016/j.cell.2008.05.039 · Cited by 562 · see citing works
Animal Cytokinesis: From Parts List to Mechanisms
Eggert, U., Mitchison, T. J., & Field, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133425 · Cited by 439 · see citing works
New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network
Dai, Y., & Grant, S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1029 · Cited by 438 · see citing works
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
Gonen, N., & Assaraf, Y. G. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.07.002 · Cited by 435 · see citing works
Spindle Multipolarity Is Prevented by Centrosomal Clustering
Quintyne, N. J., Reing, J. E., Hoffelder, D. R., Gollin, S. M., & Saunders, W. S. (2005) · Science · doi:10.1126/science.1104905 · Cited by 431 · see citing works
Aneuploidy: Cells Losing Their Balance
Torres, E. M., Williams, B. R., & Amon, A. (2008) · Genetics · doi:10.1534/genetics.108.090878 · Cited by 409 · see citing works
Managing the centrosome numbers game: from chaos to stability in cancer cell division
Brinkley, B. R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01872-9 · Cited by 402 · see citing works
Chk2 activates E2F-1 in response to DNA damage
Stevens, C., Smith, L. M., & Thangue, N. B. L. (2003) · Nature Cell Biology · doi:10.1038/ncb974 · Cited by 386 · see citing works
A Clinical Overview of Centrosome Amplification in Human Cancers
Chan, J. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1122 · Cited by 380 · see citing works
Survivin: A new target for anti-cancer therapy
Ryan, B. M., O’Donovan, N., & Duffy, M. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.05.003 · Cited by 378 · see citing works
How do anti-mitotic drugs kill cancer cells?
Gascoigne, K. E., & Taylor, S. S. (2009) · Journal of Cell Science · doi:10.1242/jcs.039719 · Cited by 375 · see citing works
Liu, S., Sawada, T., Lee, S., Yu, W., Silverio, G., Alapatt, P., Millan, I., Shen, A., Saxton, W., Kanao, T., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002537 · Cited by 371 · see citing works
The consequences of tetraploidy and aneuploidy
Storchova, Z., & Kuffer, C. (2008) · Journal of Cell Science · doi:10.1242/jcs.039537 · Cited by 363 · see citing works
Harley, M. E., Allan, L. A., Sanderson, H. S., & Clarke, P. R. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.112 · Cited by 355 · see citing works
Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1–C-Mad2 core complex
Hewitt, L., Tighe, A., Santaguida, S., White, A. M., Jones, C. D., Musacchio, A., Green, S. A., & Taylor, S. S. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201002133 · Cited by 325 · see citing works
Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells
Janssen, A., Kops, G. J. P. L., & Medema, R. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904343106 · Cited by 317 · see citing works
DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway
Kang, M. A., So, E.-Y., Simons, A. L., Spitz, D. R., & Ouchi, T. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.134 · Cited by 311 · see citing works
Labi, V., & Erlacher, M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.20 · Cited by 296 · see citing works
A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidizationPreprint
Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H., & Oren, M. (2006) · Genes & Development · doi:10.1101/gad.1447006 · Cited by 284 · see citing works
Apoptosis and non-apoptotic deaths in cancer development and treatment response
de Bruin, E. C., & Medema, J. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.001 · Cited by 277 · see citing works
Spatiotemporal regulation of the anaphase-promoting complex in mitosis
Sivakumar, S., & Gorbsky, G. J. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3934 · Cited by 261 · see citing works
A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.
Kracikova, M., Akiri, G., George, A., Sachidanandam, R., & Aaronson, S. A. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.155 · Cited by 261 · see citing works
Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease
Gentric, G., Maillet, V., Paradis, V., Couton, D., L’Hermitte, A., Panasyuk, G., Fromenty, B., Celton-Morizur, S., & Desdouets, C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73957 · Cited by 240 · see citing works
PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2
Yang, S., Kuo, C. S., Bisi, J., & Kim, M. K. (2002) · Nature Cell Biology · doi:10.1038/ncb869 · Cited by 238 · see citing works
Jeganathan, K. B., Malureanu, L. A., Baker, D., Abraham, S., & van Deursen, J. (2007) · Journal of Cell Biology · doi:10.1083/jcb.200706015 · Cited by 238 · see citing works
The influence of subclonal resistance mutations on targeted cancer therapy
Schmitt, M. W., Loeb, L. A., & Salk, J. J. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.175 · Cited by 224 · see citing works
Tighe, A., Johnson, V., & Taylor, S. S. (2004) · Journal of Cell Science · doi:10.1242/jcs.01556 · Cited by 222 · see citing works
Kinesin motor proteins as targets for cancer therapy
Huszar, D., Theoclitou, M., Skolnik, J. M., & Herbst, R. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9185-8 · Cited by 206 · see citing works
Rationally designed nanovehicles to overcome cancer chemoresistance
Livney, Y. D., & Assaraf, Y. G. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.006 · Cited by 205 · see citing works
The detection and implication of genome instability in cancer
Pikor, L. A., Thu, K. L., Vucic, E. A., & Lam, W. L. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9429-5 · Cited by 204 · see citing works
Zimmet, J. M., & Ravid, K. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(99)00124-1 · Cited by 197 · see citing works
Mitotic spindle multipolarity without centrosome amplification
Maiato, H., & Logarinho, E. (2014) · Nature Cell Biology · doi:10.1038/ncb2958 · Cited by 190 · see citing works
Molecular basis of resistance to proteasome inhibitors in hematological malignancies
Niewerth, D., Jansen, G., Assaraf, Y. G., Zweegman, S., Kaspers, G. J. L., & Cloos, J. J. (2014) · Drug Resistance Updates · doi:10.1016/j.drup.2014.12.001 · Cited by 189 · see citing works
Spindle assembly checkpoint: the third decade
Musacchio, A. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0072 · Cited by 182 · see citing works
Identification of Griseofulvin as an Inhibitor of Centrosomal Clustering in a Phenotype-Based Screen
Rebacz, B., Larsen, T. O., Clausen, M. H., Rønnest, M. H., Löffler, H., Ho, A. D., & Krämer, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0663 · Cited by 181 · see citing works
Mitosis and apoptosis: how is the balance set?
Topham, C. H., & Taylor, S. S. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.003 · Cited by 177 · see citing works
Overexpression of KIF23 predicts clinical outcome in primary lung cancer patients
Kato, T., Wada, H., Patel, P., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.11.018 · Cited by 177 · see citing works
Daido, S., Yamamoto, A., Fujiwara, K., Sawaya, R. A., Kondo, S., & Kondo, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4202 · Cited by 175 · see citing works
The Chromosomal Basis of Cancer
DUESBERG, P. H., Li, R., Fabarius, A. C., & Hehlmann, R. (2005) · Analytical Cellular Pathology · doi:10.1155/2005/951598 · Cited by 175 · see citing works
The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe
Castedo, M., Perfettini, J., Roumier, T., Yakushijin, K., Horne, D. A., Medema, R. H., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207573 · Cited by 171 · see citing works
Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents
Nitta, M., Kobayashi, O., Honda, S., Hirota, T., Kuninaka, S., Marumoto, T., Ushio, Y., & Saya, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207873 · Cited by 167 · see citing works
Human Tousled like kinases are targeted by an ATM‐ and Chk1‐dependent DNA damage checkpoint
Groth, A., Lukáš, J., Nigg, E. A., Silljé, H. H. W., Wernstedt, C., Bartek, J. J., & Hansen, K. H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg151 · Cited by 166 · see citing works
APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in <i>Min</i> mice
Caldwell, C. M., Green, R. A., & Kaplan, K. B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703186 · Cited by 164 · see citing works
Rao, C. V., Yang, Y., Swamy, M. V., Liu, T., Fang, Y., Mahmood, R., Jhanwar‐Uniyal, M., & Dai, W. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407822102 · Cited by 160 · see citing works
ATG5 is induced by DNA-damaging agents and promotes mitotic catastrophe independent of autophagy
Maskey, D., Yousefi, S., Schmid, I., Zlobec, I., Perren, A. A., Friis, R. R., & Simon, H. (2013) · Nature Communications · doi:10.1038/ncomms3130 · Cited by 151 · see citing works
p53 protects against genome instability following centriole duplication failure
Lambrus, B. G., Uetake, Y., Clutario, K. M., Daggubati, V., Snyder, M., Sluder, G., & Holland, A. J. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201502089 · Cited by 150 · see citing works
DNA damage induces two distinct modes of cell death in ovarian carcinomas
Vakifahmetoglu, H., Olsson, M., Tamm, C., Heidari, N., Orrenius, S., & Zhivotovsky, B. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402286 · Cited by 140 · see citing works
Self-citationDNA damage and innate immunity: links and trade-offs
Chatzinikolaou, G., Karakasilioti, I., & Garinis, G. A. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.06.003 · Cited by 139 · see citing works
Langerak, P., & Russell, P. R. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0070 · Cited by 139 · see citing works
p53 regulates a non-apoptotic death induced by ROS
Montero, J., Dutta, C., van Bodegom, D., Weinstock, D. M., & Letai, A. G. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.52 · Cited by 134 · see citing works
Nordström, L., Sernbo, S., Edén, P., Grønbæk, K., Kolstad, A., Räty, R., Karjalainen, M., Geisler, C. H., Ralfkiaer, E. M., Sundström, C., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12854 · Cited by 133 · see citing works
HPV 5 and 8 E6 Abrogate ATR Activity Resulting in Increased Persistence of UVB Induced DNA Damage
Wallace, N. A., Robinson, K. L., Howie, H. L., & Galloway, D. A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002807 · Cited by 131 · see citing works
Activation of DSB Processing Requires Phosphorylation of CtIP by ATR
Peterson, S., Li, Y., Wu-Baer, F., Chait, B. T., Baer, R. J., Yan, H., Gottesman, M. E., & Gautier, J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.11.020 · Cited by 131 · see citing works
Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin
Huertas, D., Soler, M., Moretó, J., et al. (2011) · Oncogene · doi:10.1038/onc.2011.335 · Cited by 127 · see citing works
Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis
Miettinen, M. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.178 · Cited by 124 · see citing works
The Aneuploidy Paradox in Cell Growth and Tumorigenesis
Weaver, B. A. A., & Cleveland, D. W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.011 · Cited by 121 · see citing works
Microtubule assembly during mitosis – from distinct origins to distinct functions?
Meunier, S., & Vernos, I. (2012) · Journal of Cell Science · doi:10.1242/jcs.092429 · Cited by 112 · see citing works
Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor
McGowan, C. H. (2002) · BioEssays · doi:10.1002/bies.10101 · Cited by 108 · see citing works
The unpredictable caspase-2: what can it do?
Vakifahmetoglu-Norberg, H., & Zhivotovsky, B. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.12.006 · Cited by 108 · see citing works
Self-citationA mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death
Atkinson, J., Kapralov, A. A., Yanamala, N. V. K., Tyurina, Y. Y., Amoscato, A. A., Pearce, L. L., Peterson, J., Huang, Z., Jiang, J., Samhan-Arias, A. K., et al. (2011) · Nature Communications · doi:10.1038/ncomms1499 · Cited by 106 · see citing works
Schlegel, B. P., Starita, L. M., & Parvin, J. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206195 · Cited by 102 · see citing works
Checkpoint mechanisms at the intersection between DNA damage and repair
Lazzaro, F., Giannattasio, M., Puddu, F., Granata, M., Pellicioli, A., Plevani, P., & Muzi-Falconi, M. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.04.022 · Cited by 94 · see citing works
Willmore, E., Elliott, S. L., Mainou‐Fowler, T., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5158 · Cited by 94 · see citing works
Tetraploidy and tumor development
Margolis, R. L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.017 · Cited by 93 · see citing works
Cornell, L., Munck, J. M., Alsinet, C., Villanueva, A., Ogle, L. F., Willoughby, C. E., Televantou, D., Thomas, H. D., Jackson, J., Burt, A. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0842 · Cited by 88 · see citing works
Regulation of mitosis via mitotic kinases: new opportunities for cancer management
Schmit, T. L., & Ahmad, N. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0781 · Cited by 85 · see citing works
Bartek, J. J., & Lukas, J. (2003) · Nature · doi:10.1038/421486a · Cited by 81 · see citing works
Cell cycle and cell death in disease: past, present and future
Zhivotovsky, B., & Orrenius, S. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02282.x · Cited by 76 · see citing works
Self-citationiASPP and Chemoresistance in Ovarian Cancers: Effects on Paclitaxel-Mediated Mitotic Catastrophe
Jiang, L., Siu, M. K. Y., Wong, O. G., Tam, K.-F., Lü, X., Lam, E. W. ‐., Ngan, H., Le, X., Wong, E. S. Y., Monteiro, L. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0588 · Cited by 72 · see citing works
Genotoxic Stress-Induced Activation of Plk3 is Partly Mediated by Chk2
Xie, S., Wu, H., Wang, Q., et al. (2002) · Cell Cycle · doi:10.4161/cc.1.6.271 · Cited by 68 · see citing works
Selective Resistance of Tetraploid Cancer Cells against DNA Damage‐Induced Apoptosis
Castedo, M., Coquelle, A., Vitale, I., VIVET, S., Mouhamad, S., Viaud, S., Zitvogel, L., & Kroemer, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.004 · Cited by 65 · see citing works
Inhibitory Phosphorylation of Cyclin-Dependent Kinase 1 as a Compensatory Mechanism for Mitosis Exit
Chow, J. P. H., Poon, R. Y. C., & Ma, H. T. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00891-10 · Cited by 64 · see citing works
A tumor suppressor role of the Bub3 spindle checkpoint protein after apoptosis inhibition
da Silva, S. M., Moutinho‐Santos, T., & Sunkel, C. E. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201210018 · Cited by 63 · see citing works
Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients
Kato, T., Daigo, Y., Aragaki, M., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.01.025 · Cited by 62 · see citing works
Azad, A., Jackson, S., Cullinane, C. M., Natoli, A. L., Neilsen, P. M., Callen, D. F., Maira, S.-M., Hackl, W., McArthur, G. A., & Solomon, B. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0312 · Cited by 61 · see citing works
Targeting the DNA Double Strand Break Repair Machinery in Prostate Cancer
Shaheen, F. S., Znojek, P., Fisher, A. M., Webster, M., Plummer, R., Gaughan, L., Smith, G. C. M., Leung, H. Y., Curtin, N. J., & Robson, C. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020311 · Cited by 57 · see citing works
Ekman, S., Frödin, J., Harmenberg, J., et al. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.499370 · Cited by 52 · see citing works
Yu, L., Yang, L., An, W., & Su, X. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24711 · Cited by 49 · see citing works
Mitochondrial Alterations During Carcinogenesis
Wang, X., Peralta, S., & Moraes, C. T. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00004-6 · Cited by 46 · see citing works
Chromosomes, genes, and cancer.
Nowell̀, P. C., & Croce, C. M. (1986) · PubMed · Cited by 45 · see citing works
p53 suppresses structural chromosome instability after mitotic arrest in human cells
Dalton, W. B., Yu, B., & Yang, V. W. (2010) · Oncogene · doi:10.1038/onc.2009.477 · Cited by 45 · see citing works
Majuelos‐Melguizo, J., Rodríguez, M. I., López-Jiménez, L., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2993 · Cited by 41 · see citing works
Pérès, E. A., Gérault, A. N., Valable, S., Roussel, S., Toutain, J., Divoux, D., Guillamo, J., Sanson, M., Bernaudin, M., & Petit, E. (2014) · Oncotarget · doi:10.18632/oncotarget.2937 · Cited by 41 · see citing works
Determinants of Mitotic Catastrophe on Abrogation of the G2 DNA Damage Checkpoint by UCN-01
On, K. F., Chen, Y., Ma, H. T., Chow, J. P. H., & Poon, R. Y. C. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0809 · Cited by 40 · see citing works
Bimodal activation of BubR1 by Bub3 sustains mitotic checkpoint signaling
Han, J. S., Vitre, B., Fachinetti, D., & Cleveland, D. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416277111 · Cited by 37 · see citing works
The Effect of Gamma Radiation on Cellsin VivoPart II
Glucksmann, A., & Spear, F. G. (1939) · British Journal of Radiology · doi:10.1259/0007-1285-12-140-486 · Cited by 36 · see citing works
Waraky, A., Akopyan, K., Parrow, V., Strömberg, T., Axelson, M., Abrahmsén, L., Lindqvist, A., Larsson, O., & Aleem, E. A. (2014) · Oncotarget · doi:10.18632/oncotarget.2292 · Cited by 33 · see citing works
Causes and consequences of protein folding stress in aneuploid cells
Donnelly, N., & Štorchová, Z. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1006043 · Cited by 28 · see citing works
Tumor suppressor roles of CENP-E and Nsl1 inDrosophilaepithelial tissues
Clemente‐Ruiz, M., Muzzopappa, M., & Milán, M. (2014) · Cell Cycle · doi:10.4161/cc.28417 · Cited by 26 · see citing works
Securin predicts aneuploidy and survival in breast cancer
Karra, H., Pitkänen, R., Nykänen, M., Talvinen, K., Kuopio, T., Söderström, M., & Kronqvist, P. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04107.x · Cited by 24 · see citing works
Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
Teicher, B. A., & Bonavida, B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-474-2 · Cited by 17 · see citing works
Pathologic mitoses and pathology of mitosis in tumorigenesis
Steinbeck, R. (2009) · European Journal of Histochemistry · doi:10.4081/1640 · Cited by 16 · see citing works
Mitochondrial induction as a potential radio-sensitizer in lung cancer cells - a short report
Shavit, R., Ilouze, M., Feinberg, T., et al. (2015) · Cellular Oncology · doi:10.1007/s13402-014-0212-6 · Cited by 15 · see citing works
Chromosomes, Genes, and Cancer
Nowell̀, P. C., & Croce, C. M. (1987) · The Journal of Urology · doi:10.1016/s0022-5347(17)44374-6 · Cited by 15 · see citing works
Trisomy 9 mosaicism and XX sex reversal
Solomon, B. D., Turner, C., Klugman, D., et al. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31996 · Cited by 9 · see citing works
Mitochondria — a bullseye in cancer therapy
Gogvadze, V. G., & Zhivotovsky, B. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.10.002 · Cited by 4 · see citing works
Self-citationIs aneuploidy deciding your fate?
Rowald, K. (2014) · Cell Cycle · doi:10.4161/cc.28753 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works
Self-citation
- Authors
- Denisenko, T. V., Sorokina, I. V., Gogvadze, V., & Zhivotovsky, B.
- Affiliations
- Lomonosov Moscow State University (RU)
- Corresponding author
- Zhivotovsky, Boris
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 24
- Pages
- 1-12
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2176757944
- Cited by
- 108
- References
- 126
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 14 · 2023: 12 · 2022: 13 · 2021: 13 · 2020: 9 · 2019: 6 · 2018: 11 · 2017: 11 · 2016: 7
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Resistance Updates (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Russian Foundation for Basic Research
- Russian Science Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- mitotic catastrophe, chemoresistance, genomic instability, aneuploidy, tetraploidy, apoptosis, necrosis, oncosuppression, cancer cell death, chemotherapeutic drugs
- MeSH terms
- Antineoplastic Agents, Cell Cycle, DNA Damage, Humans, Mutation, Neoplasms, Apoptosis, Drug Resistance, Neoplasm, Genomic Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review